Skip to main content
. 2025 Mar 7;17(3):385. doi: 10.3390/v17030385

Figure 6.

Figure 6

Activity in human primary mucociliary airway stem cell-based SARS-CoV-2 infection model for compound 4 compared to remdesivir and molnupiravir tested at 10 µM.